OMC Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5M Sell
53,770
-151
-0.3% -$32.5K 4.48% 6
2026
Q1
$11.7M Buy
53,921
+2,839
+6% +$630K 4.55% 6
2025
Q4
$11.7M Sell
51,082
-589
-1% -$134K 4.35% 7
2025
Q3
$12M Buy
51,671
+148
+0.3% +$30.1K 4.44% 7
2025
Q2
$9.56M Sell
51,523
-473
-0.9% -$87.9K 3.91% 7
2025
Q1
$10.9M Sell
51,996
-29
-0.1% -$5.64K 4.89% 6
2024
Q4
$9.24M Buy
52,025
+2,276
+5% +$418K 3.93% 7
2024
Q3
$8.53M Hold
49,749
4.03% 6
2024
Q2
$8.53M Sell
49,749
-366
-0.7% -$60.6K 4.02% 6
2024
Q1
$9.13M Buy
+50,115
New +$8.64M 4.64% 6

Other funds holding ABBV

OMC Financial Services's ABBV Position: Q2 2026 in Review

OMC Financial Services reduced its AbbVie (ABBV) stake by 0.28% in Q2 2026, selling an estimated $32.5K and leaving 53,770 shares worth $13.5M. The position accounts for 4.48% of the portfolio, ranked #6.

OMC Financial Services first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • OMC Financial Services held 53,770 shares of AbbVie worth $13.5M as of Q2 2026.
  • OMC Financial Services sold 151 AbbVie shares in Q2 2026, an estimated $32.5K.
  • AbbVie made up 4.48% of OMC Financial Services's portfolio in Q2 2026, its #6 holding.
  • OMC Financial Services first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on OMC Financial Services's 13F filing for Q2 2026, filed 6 Aug 2026.